(E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide

We are (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide CAS:863127-76-8 manufacturer and supplier in China, Pls send inquiry of to info@nbinno.com of visit www.nbinno.com our official website should you have any interests

Chemical Name: (E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide
CAS.NO:863127-76-8
Synonyms:
2-Propenamide, N-(2-chloro-6-methylphenyl)-3-ethoxy-, (2E)-
(2E)-N-(2-Chloro-6-methylphenyl)-3-ethoxyacrylamide

Molecular Formula: C12H14ClNO2
Molecular Weight:239.69800

Physical and Chemical Properties:
Density: 1.197 g/cm3
Boiling point: 386.5ºC at 760 mmHg
Melting point: /
Flash point:187.6±27.9 °C
Refractive index: 1.572

Specification:
Appearance: Light yellow or light brown powder
Purity:≥99%
Moisture Content: 0.02%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Dasatinib CAS:302962-49-8
Intermediates of Dasatinib monohydrate CAS:863127-77-9

Related News: The Company has established a leadership position in the clinical development and manufacture of universal, off-the-shelf cell products using its proprietary induced pluripotent stem cell (iPSC) product platform.5-Ethyl-2-[2-(4-nitrophenoxy)ethyl]pyridine Rigosertib, in its intravenous formulation, is currently in Phase 3 clinical development for the treatment of higher-risk MDS.2-Amino-5-bromo-3-nitropyridine CAS:6945-68-2 At the same time, due to the relatively late development of the bulk drug business in China, most of the established bulk drug companies are currently in the field of commonly used generic drug bulk drugs. Stand up.2-cloro-6-fluorobenzaldehído CAS:387-45-1 When using the raw materials, as an API manufacturer we produce API in the large reactor in our plant.However, compared with the 60-70% refinement rate in developed economies such as North America, Western Europe, and Japan, China is still only equivalent to the level of the United States in the 1980s. There is still a lot of room for improvement in China’s refinement rate. period.